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Abstract
Background: With the premise of diminishing parasite genetic diversity following the reduction of malaria incidence,
the analysis of polymorphic antigenic markers may provide important information about the impact of malaria control
on local parasite populations. Here we evaluated the genetic diversity of Plasmodium vivax apical membrane
antigen 1 (Pvama1) gene in a parasite population from the China-Myanmar border and compared it with global
P. vivax populations.
Methods: We performed evolutionary analysis to examine the genetic diversity, natural selection, and population
differentiation of 73 Pvama1 sequences acquired from the China-Myanmar border as well as 615 publically available
Pvama1 sequences from seven global P. vivax populations.
Results: A total of 308 Pvama1 haplotypes were identified among the global P. vivax isolates. The overall nucleotide
diversity of Pvama1 gene among the 73 China-Myanmar border parasite isolates was 0.008 with 41 haplotypes being
identified (Hd = 0.958). Domain I (DI) harbored the majority (26/33) of the polymorphic sites. The McDonald Kreitman
test showed a significant positive selection across the ectodomain and the DI of Pvama1. The fixation index (FST)
estimation between the China-Myanmar border, Thailand (0.01) and Myanmar (0.10) showed only slight geographical
genetic differentiation. Notably, the Sal-I haplotype was not detected in any of the analyzed global isolates, whereas
the Belem strain was restricted to the Thai population. The detected mutations are mapped outside the overlapped
region of the predicted B-cell epitopes and intrinsically unstructured/disordered regions.
Conclusions: This study revealed high levels of genetic diversity of Pvama1 in the P. vivax parasite population from the
China-Myanmar border with DI displaying stronger diversifying selection than other domains. There were low levels of
population subdivision among parasite populations from the Greater Mekong Subregion.
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Background
In South and Southeast Asia, Latin America and Oceania,
Plasmodium vivax is the major malaria species; around
2.5 billion people are living in areas of P. vivax trans-
mission [1]. In the Greater Mekong Subregion (GMS)
where countries are pursuing regional malaria elimination
(www.apmen.org), P. vivax is often sympatric with P. fal-
ciparum, P. ovale and P. malariae [2], although P. vivax
has become the predominant species in recent years [3].
With the ability to form hypnozoites that are responsible
for relapses, P. vivax presents a major challenge for mal-
aria elimination. Within the GMS, malaria is distributed
very unevenly; malaria transmission is concentrated along
international borders, whereas central plains are mostly
free from malaria [3, 4]. The more intensified control
efforts in this region have led to a further reduction of
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malaria incidence, creating isolated areas or pockets of
high malaria prevalence separated by areas with extremely
low endemicity or malaria-free zones. In China, autoch-
thonous malaria incidence is mostly located in counties
bordering with Myanmar, where malaria burden is the
highest in the GMS [5, 6]. In these border regions, cross-
border human migration as a major source of malaria
introduction presents a significant challenge to the mal-
aria elimination course [7, 8]. Since control efforts are ex-
pected to have great impacts on the genetic diversity of
the parasite populations [9, 10], tracking their spatial and
temporal dynamics may provide timely measurement of
the progress of regional malaria elimination.
The genetic diversity of antigens in malaria parasites
has been extensively studied not only because of their
importance as malaria vaccine candidates [11], but also
due to their usefulness as molecular markers for differ-
entiating parasite populations. Several P. vivax proteins,
including Duffy-binding protein (DBP), apical membrane
antigen 1 (AMA1), and merozoite surface proteins (MSPs),
have been selected as vaccine candidates for their essential
functions during erythrocytes invasion and their antigenic-
ity in natural host immune response [12–15]. Among
them, AMA1 has been identified as an essential target of
the host immune system, and considered an attractive mal-
aria vaccine candidate [15–17]. The ama1 gene has been
extensively studied in a number of Plasmodium species
[18]. As a type I transmembrane protein, AMA1 is secreted
by microneme organelles. Together with RON proteins,
AMA1 is involved in merozoite reorientation and tight
junction formation during the invasion process [19–24].
Antibodies raised against the AMA1 ectodomain have
been shown to inhibit erythrocyte invasion, and AMA1
immunization protects against malaria infection [15, 25–27].
The ectodomain of AMA1 was divided into three subdo-
mains referred to as Domain I (DI), Domain II (DII) and
Domain III (DIII) based on the conserved cysteine residues
[28]. DI harbors higher levels of genetic variation compared
to DII and DIII, suggesting this domain is a target of the
host immune system [29]. Within DI of PfAMA1, eight
polymorphic amino acids located in the cluster 1 loop (c1L)
were identified as the targets of allele-specific, protective im-
mune response [30]. Evidence of diversifying selection was
observed in DII of AMA1 in some studies such as in the Sri
Lankan parasites, suggesting that this region may also be
targeted by host immunity [31, 32]. In addition, serological
studies showed that DII is the most immunogenic of the
three domains [33]. Due to the highly polymorphic feature
of the ama1 gene, it has been used as a molecular marker
for population genetic studies [34, 35].
Although the genetic diversity of P. vivax ama1
(Pvama1) has been extensively studied with samples
from Asia, Oceania and South America [36–39], there is
a relative lack of data from Southeast Asia, where parasite
populations are now being restricted to the international
borders as the regional malaria elimination program is
unfolding. Thus, in this study, we aimed to investigate
the genetic diversity of Pvama1 gene from the China-
Myanmar border area. We wanted to determine whether
this potentially isolated parasite population was genetically
different from those of other endemic regions. Further-
more, we wanted to learn whether the intensified malaria
control efforts resulted in evident reduction of genetic di-
versity of the parasite population as observed elsewhere in
Southeast Asia [9]. Our study revealed a considerably high
level of genetic diversity of the Pvama1 gene in the
China-Myanmar border parasite population.
Methods
Study sites and isolates
Parasite sample collection was carried out from April 2011
to October 2012 around the township of Laiza, which
is located in the northeast Kachin State, along the
China-Myanmar border [40]. This region has a subtropical
climate with most of the precipitation occurring in
June-August (the rainy season). The majority of the local
inhabitants are ethnic Kachin (called Jingpo in China) with
farming being their major occupation. In recent years,
there has been a considerable decline of annual malaria
incidence and P. vivax has become the predominant para-
site species [40, 41]. Like other international borders
within the GMS, the China-Myanmar border also has ex-
perienced an increase in cross-border migration with large
migrant populations engaging in international trade,
logging, quarry, plantation and construction activities,
which may play an important role for introducing mal-
aria [8, 42]. Filter paper blood spots were collected as
our passive malaria case detection efforts in the town-
ship hospital and clinics servicing surrounding villages
and two camps for internally displaced people. P. vivax
infections were based on microscopy of Giemsa-stained
thick smears. The study protocol was approved by the
IRB of Pennsylvania State University and by the Health
Department of Kachin.
DNA extraction, amplification and sequencing of the
PvAMA1 gene
Genomic DNA from dried filter paper blood spots of
slide-positive samples was extracted by using a QIAamp
DNA Blood Mini kit (QIAGEN, Hilden, Germany). A
DNA fragment of the Pvama1 gene encoding the extracel-
lular region (1,290 bp, nucleotide region (nt) 148–1,437 of
the Sal-I sequence; GenBank accession no. AF063138) was
amplified and sequenced with six oligonucleotide primers
listed in Additional file 1: Table S1. The amplifications
were performed in a 20 μl volume reaction containing 1×
KOD-Plus-Neo buffer, 200 μM dNTPs, 1 mM MgSO4, 250
nM of each primer, 0.4 units of KOD Plus neo polymerase
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(Toyobo, Osaka, Japan), and 1 μl genomic DNA as
template. The reaction was run at 94 °C for 5 min, followed
by 45 cycles of 94 °C for 15 s, 56 °C for 15 s, and 68 °C for
90 s, and extension at 68 °C for 5 min. PCR fragments were
analyzed by electrophoresis on a 1.2% agarose gels. Direct
sequencing of purified PCR fragments was carried out on
both strands with primers listed in Additional file 1:
Table S1 by using the ABI BigDye™ Terminator Reaction
Ready kit (Applied Biosystems, CA, USA).
Sequence assembling and polymorphism analysis
Of the 78 P. vivax infections amplified by PCR, five sam-
ples showing dual peaks suggestive of a mixed infection
were excluded from further analysis. Pvama1 was success-
fully sequenced from 73 samples (sequences submitted to
GenBank under accession nos. KX495505–KX495577). A
single contiguous 1,290 bp of Pvama1 (nt 148–1,437 and
codons 50–479) was derived for each of the 73 Pvama1
sequences, which include DI (codons 94–247), DII (co-
dons 265–363) and DIII (codons 388–451). The consen-
sus of the sequences were aligned to the P. vivax Sal-I
strain by using the CLUSTAL W program in MEGA6.0
[43]. Seven primate-adapted P. vivax isolates (Belem,
Chesson I, India VII, Indonesia XIX, North Korea, Palo
Alto and Simium; GenBank accession nos EU395595–
EU395601) were also analyzed as additional reference se-
quences [44]. Aligned sequences were exported as FASTA
alignment for statistical analysis using the DnaSP v5.10.01
software [45]. Sequencing was repeated to confirm single-
tons. The numbers of segregating sites (S), the total num-
ber of mutations (η), the average number of pairwise
nucleotide differences (k), nucleotide diversity (π), the
number of haplotypes (H) and haplotype diversity (Hd),
and their corresponding standard deviation were com-
puted using the options available in DnaSP v5.10.01 soft-
ware [45]. The distribution of nucleotide diversity (π)
across the DI-III of Pvama1 gene was analyzed using the
sliding window approach.
Haplotype network construction, linkage disequilibrium
(LD) and FST analysis
A haplotype network based on the Pvama1 sequence
was constructed by using the NETWORK software
Version 4.6.1.3 with the Median-Joining method [46]. A
total of 534 publically available Pvama1 sequences repre-
senting seven P. vivax populations were retrieved from
the GenBank: South Korea [47], India [38], Sri Lanka [32],
Thailand [48], Iran [49], Venezuela [50], and Papua New
Guinea (PNG) [37]. LD was performed to calculate the
minimum number of recombination events (RM) [51] and
to give an estimation of the recombination parameter C
[52]. The relationship between LD and distance between
nucleotide sites was plotted by using indices D’ [53] and
R2 [54]. To assess the proportion of genetic variance due
to population subdivision, Wright’s FST among populations
were calculated by using DnaSP v5.10.01 [45].
Statistical and phylogenetic analysis
To determine departure from neutrality, Tajima’s D, Fu
and Li’s D* and F*, and McDonald-Kreitman indices
were calculated using DnaSP v5.10.01 and via a sliding
window method [45]. In Tajima’s D test, departure from
neutrality is determined by comparing the values of θ
(estimated nucleotide diversity) derived from π (observed
average pairwise nucleotide diversity) and the total num-
ber of segregating sites (S) [55]. The Fu and Li’s D* and F*
tests determine departure from neutrality by differences
between estimation of θ derived from the number of sin-
gletons and that based on either the total number of mu-
tations (D*) or the average pairwise diversity (F*) [56]. The
McDonald-Kreitman test [57] was applied by using a sin-
gle P. cynomolgi ama1 sequence (GenBank accession no.
X86099; [58]) as the outgroup for comparison with the P.
vivax populations. It allows for determination of the ratio
of synonymous substitutions to nonsynonymous substitu-
tions between and within species. A two-tailed Fisher’s
exact test was computed to determine the statistical
significance (P < 0.05). A phylogenetic analysis of Pvama1
sequences (nt 322–737 relative to Sal-I strain) with
Myanmar samples [59] was performed by the neighbor-
joining (NJ) method in the MEGA 6.0 software [43]. The
bootstrap method with 1,000 replications was used to
assess the reliability of the gene tree.
Structural modelling of PvAMA1
The potential B cell epitopes of DI-III in PvAMA1 were
predicted by using the ABCpred server [60]. In order to
consider a given region as a valid linear B-cell epitope, a
threshold of 0.7 was used to predict the 16 residues. The
prediction of intrinsically unstructured/disordered re-
gions (IURs) in proteins, which is highly desirable in the
design of vaccines and diagnostic tests, was carried out
using the RONN server [61]. Residues with an output
score above 0.5 were regarded as disordered. The over-
lapped regions between B-cell epitopes and IURs, as well
as mutation sites across DI-III were mapped on a three
dimensional structure of PvAMA1 (Protein Data Bank
ID: 1W8K; [28]). ViewerLite 4.2 was used to visualize the
surface distribution of mapped IURs, the polymorphism,
and B-cell epitopes on the crystal structure of PvAMA1.
Results
Genetic diversity of Pvama1 among P. vivax isolates from
the China-Myanmar border
The 1,290 bp sequence corresponding to the ectodomain
(nt 148–1,437 encoding amino acids 50–479 relative to
the Sal-I strain) of Pvama1 was amplified from 73 P. vivax
samples acquired from the China-Myanmar border. Of
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the 73 Pvama1 sequences, there were 41 haplotypes, giv-
ing overall haplotype diversity (Hd) of 0.958 (Table 1). The
average number of pairwise nucleotide differences (k) for
the entire 1,290 bp sequenced region, DI, DII, and DIII
were 10.895, 7.433, 1.385, and 0.419, respectively (Table 1).
A total of 46 SNPs was detected, including 13 syn-
onymous and 33 non-synonymous (Table 2). Nucleo-
tide diversity (π) at DI, DII and DIII of Pvama1 among
73 examined P. vivax isolates was 0.016, 0.005, and
0.002, respectively, giving an overall π value of the se-
quenced region of 0.008 (Table 1). A sliding window
plot of π with a window of 90 bp and step size of 3 bp
revealed values ranging from 0.000 to 0.023 (Fig. 1a).
The ectodomain contained 43 polymorphic sites, of which
four (nt 162, 957, 1377, 1412) were novel compared to
previous reports [32, 37, 38, 47–50]. The majority of
polymorphic sites were identified in DI (26 sites) and
DII (5 sites) as compared to two sites in DIII (Fig. 1b).
Of these polymorphic sites, five were trimorphic, while
the rest were dimorphic, displaying only two alternative
amino acids (Fig. 1b). Within DI, 10 of the 26 Pvama1
mutations were mapped to the same positions as the
Pfama1 c1, c1L, c2, and c3 clusters. Among them, four
mapped to the c1 cluster, and one was located within
the Pvama1 c1L cluster (Additional file 2: Figure S1).
Genetic diversity of Pvama1 in the eight worldwide
parasite populations
The Pvama1 sequences obtained from the China-Myanmar
border (n = 73) were then compared to previously pub-
lished sequences from seven other geographic regions and
primate-adapted P. vivax isolates (nt 148–1,437 encoding
amino acids 50–479). A total of 117 mutations were
identified among the 615 global and reference Pvama1
sequences, including 38 synonymous SNPs (SP SNPs)
and 79 non-synonymous SNPs (NS SNPs) (Table 2).
The majority of the NS SNPs (53.2%) were clustered within
DI, resulting in a peak nucleotide diversity (π = 0.020)
for this region (Additional file 3: Figure S2). A total of
308 haplotypes were identified among these global
isolates, demonstrating an extremely high level of
haplotype diversity (Hd = 0.988). Nucleotide diversity
was the highest in the Iranian and Thai populations
and lowest in the South Korean population (Table 2).
Despite that the majority of haplotypes was unique to
the China-Myanmar border and Myanmar populations,
Pvama1 sequences from the China-Myanmar border
population did not form distinct clades with the Myanmar
isolates [59] by phylogenetic analyses (Additional file 4:
Figure S3).
Recombination and linkage disequilibrium
Analysis of the ectodomain of Pvama1 from the China-
Myanmar border samples provided estimates of the
minimum number of recombination events of six, while
values of the recombination parameter C between adja-
cent sites and per gene were 0.043 and 25.5, respectively
(Table 3). These values within the China-Myanmar border
population were higher compared to estimates from the
South Korea, India, Sri Lanka and Venezuela populations,
but lower than those of the Thailand, PNG and Iran popu-
lations, respectively (Table 3). Figure 2 shows the relation-
ship between R2, D’ with distance between sites. This LD
analysis showed a decline of the LD index (R2) with in-
creasing nucleotide sites distance within the Pvama1 gene
of the China-Myanmar border isolates, indicating a high
meiotic recombination rate (Fig. 2).
FST analysis
In order to understand the distribution of diversity across
global populations, FST values of the China-Myanmar
border population and seven worldwide populations with
full-length ectodomain sequences were evaluated [45]. A
high level of genetic differentiation (FST = 0.47) was de-
tected between the South Korean population and the
China-Myanmar border population, whereas a low to
moderate level of genetic differentiation was detected
among other worldwide populations (ranging from 0.03
to 0.24). A moderate range of FST values (0.13–0.16)
were detected when comparing the China-Myanmar
border populations with the India, Iran, Venezuela, and
PNG populations, but a much lower genetic difference
Table 1 Nucleotide diversity and summary statistics of Pvama1 in 73 P. vivax isolates from the China-Myanmar border area. The total
sequenced region includes codons 50 to 479: Domain I codons 94 to 247 (nt, 280–741), Domain II codons 265 to 363 (nt, 793–1,089),
and Domain III codons 388 to 451 (nt, 1,162–1,353)
k H Hd ± SD S η π ± SD θ ± SD D D* F* MK
Total 10.895 41 0.958 ± 0.014 43 46 0.008 ± 0.000 0.007 ± 0.002 0.495 0.772 0.796 0.0001***
D I 7.433 27 0.919 ± 0.022 26 28 0.016 ± 0.000 0.012 ± 0.004 0.912 0.269 0.608 0.004**
D II 1.385 9 0.783 ± 0.031 5 5 0.005 ± 0.000 0.003 ± 0.002 0.780 1.064 1.142 0.064
D III 0.419 3 0.330 ± 0.004 2 2 0.002 ± 0.000 0.002 ± 0.002 0.031 0.712 0.589 0.478
Abbreviations: SD standard deviation, k the average number of nucleotide differences, H number of haplotypes, Hd haplotype diversity, S number of polymorphic
(segregating) sites, η the total number of mutations, π pairwise nucleotide diversity, θ the expected nucleotide diversity under neutrality derived from S. D
Tajima’s D test, D* Fu and Li’s D* value, F* Fu and Li’s F* value, MK McDonald-Kreitman test
**P < 0.01; ***P < 0.0001
Zhu et al. Parasites & Vectors  (2016) 9:614 Page 4 of 12
was identified when comparing the China-Myanmar
border population with the Thai population (FST = 0.03)
(Table 4). Low FST values (0.01–0.10) were also observed
when comparing part of Pvama1 DI (nt 322–737) among
Myanmar, Thai and China-Myanmar border populations
(Additional file 5: Table S2).
Evidence of positive diversifying selection on Pvama1 gene
To examine whether natural selection contributed to the
generation of the diversity in Pvama1 of the China-
Myanmar border P. vivax population, Tajima’s D and Fu
and Li’s D* and F* were performed. The values of
Tajima’s D and Fu and Li’s D* and F* indices for the entire
ectodomain and each domain separately are displayed in
Table 1. Even though these values were not statistically
significant, the positive value indicates deviation from
neutral evolution and the tendency for positive diversify-
ing selection. Meanwhile, a sliding window plot depicted
significant positive values in DI, suggesting positive
diversifying selection in this region (Fig. 3). Examination
of the two sequence sets using a McDonald-Kreitman test
showed that the entire sequenced region, particularly
within DI, had significantly more non-synonymous substi-
tutions than expected from comparison with P. cynomolgi
(P < 0.0001 and P = 0.0037). This result suggests that
polymorphisms found for Pvama1, especially in the DI,
are maintained by diversifying selection, presumably due
to host immune pressure.
Table 2 Genetic diversity of Pvama1 in eight worldwide populations
Region Country n S η k π ± SD NS SP H Hd ± SD GenBank accession numbers
East Asia China-Myanmar 73 43 46 10.895 0.008 ± 0.000 33 13 41 0.958 ± 0.014 KX495505–KX495577
Korea 66 56 56 7.620 0.006 ± 0.000 35 21 27 0.950 ± 0.013 KM230319–KM230384
South Asia India 10 27 25 10.822 0.008 ± 0.001 20 5 7 0.911 ± 0.077 EF025187–195, 197
Sri Lanka 23 34 32 10.130 0.008 ± 0.000 27 5 15 0.949 ± 0.028 EF218679–EF218701
Southeast Asia Thailand 231 52 46 11.927 0.009 ± 0.000 34 12 94 0.934 ± 0.012 FJ784891–FJ785121
West Asia Iran 29 40 43 12.936 0.010 ± 0.000 34 9 29 1.000 ± 0.009 JX624732–JX624760
South America Venezuela 73 27 25 9.419 0.007 ± 0.000 19 6 18 0.909 ± 0.016 EU346015–EU346087
Oceania PNG 102 39 38 10.668 0.008 ± 0.000 31 7 83 0.995 ± 0.002 KC702402–KC702503
Reference strains 8 43 45 15.607 0.012 ± 0.002 36 9 7 0.964 ± 0.077 EU395595–EU395601
Total 615 130 117 13.497 0.010 ± 0.000 79 38 308 0.988 ± 0.002
Abbreviations: n number of samples, S number of polymorphic sites, η the total number of mutations, k the average number of nucleotide differences, π nucleotide diversity,
NS number of non-synonymous polymorphisms, SP number of synonymous polymorphisms, H number of haplotypes, Hd haplotype diversity, SD standard deviation
Fig. 1 Patterns of nucleotide diversity (a) and amino acid polymorphism
(b) of Pvama1. A scheme of the ectodomain of Pvama1 is shown below.
Nucleotide and amino acid positions are after the Sal-I sequence
Table 3 Comparison of different estimates of recombination
events in Pvama1 among worldwide isolates
Locality (no.) Ra Rb Rm
China-Myanmar (73) 0.043 25.5 6
South Korea (66) 0.003 1.6 2
India (10) 0.036 21.1 5
Sri Lanka (23) 0.012 7.2 5
Thailand (231) 0.047 27.8 10
Iran (29) 0.067 39.9 8
Venezuela (73) 0.021 12.5 5
PNG (102) 0.054 32 8
Abbreviations: Ra recombinant parameter between adjacent sites, Rb recombinant
parameter for the whole gene, Rm minimum number of recombination events,
China-Myanmar China-Myanmar border population, PNG Papua New
Guinea population
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Haplotype network reconstruction
On the basis of the 34 polymorphisms in the Pvama1 DI
global isolates, 162 unique haplotypes were identified in
615 sequences, of which 54.9% was singleton. Individual
haplotype prevalence ranged from 0.6 to 45.1%. Of the
reference strain Pvama1 sequences, only the Belem
haplotype was detected, but was restricted to the Thai
population. No haplotype matched that of the Sal-I
strain. Twelve of the 27 China-Myanmar border haplo-
types (44.4%) were shared with other populations, of
which 91.7% (11/12) were identical to some of the
Pvama1 haplotypes observed in the Thai population.
Haplotype 21 is the predominant haplotype both in the
China-Myanmar border and Thai populations, with a
frequency of 24.7% and 23.8%, respectively. Intriguingly,
an independent haplotype analysis performed among the
China-Myanmar border, Myanmar, and Thai populations
indicates that Haplotype 21 is also the only haplotype
shared among these three populations (Additional file 6:
Figure S4). Haplotype 10 is shared among the China-
Myanmar border, Indian, Sri Lankan, Thai and Iranian
populations, with a frequency of 2.7, 10.0, 30.4, 2.6, and
10.3%, respectively. Haplotype 30 is the only haplotype
shared between the China-Myanmar border population
and the outside Asian population. The haplotype network,
drawn by excluding the 89 singletons and ≤ 2% frequency
haplotypes from the analysis, showed that clusters from
the South American, Oceania, and Asian populations
overlapped (Fig. 4).
Analysis of PvAMA1 structure and antigenicity
To determine the distribution of the B-cell epitopes, IURs,
and the polymorphic residues found within the China-
Myanmar border population, the modeled structure of
PvAMA1 was used. The potential B-cell epitopes were
identified across the ectodomain of PvAMA1, which also
overlap with the locations of most of the SNPs (Additional
file 7: Figure S5). Also, the putative IURs are distributed in
five regions (amino acids - aa: 121–141, 171–183, 291–
309, 392–406, and 427–441) within all three domains of
the PvAMA1 protein with no polymorphic residues de-
tected in aa 171–183 and 291–309. In Fig. 5, the overlap
between the putative B-cell epitopes and IURs have been
demonstrated in the 3-D model of PvAMA1 in yellow
(with polymorphic residues, aa: 121–141, 392–406, and
427–441) and red colors (without polymorphic residues,
aa: 171–183 and 291–309), respectively. The polymorphic
residues clustered on one side of the PvAMA1 protein.
Interestingly, the two overlapping non-polymorphic resi-
dues of the B-cell epitopes and IURs are located on the
opposing faces of the PvAMA1 protein (Fig. 5).
Fig. 2 Linkage disequilibrium plots of R2 (a) and D’ (b) for Pvama1
gene. Sites with significant linkage (P < 0.05) as calculated by
Fisher’s exact test are shown as red circles, while all others are
shown as black circles. Trace line represents the regression line
Table 4 Geographical difference in Pvama1 sequences across all domains
Locality (n) China-Myanmar South Korea India Sri Lanka Thailand Iran Venezuela
China-Myanmar (73)
South Korea (66) 0.47
India (10) 0.13 0.39
Sri Lanka (114) 0.24 0.54 0.20
Thailand (231) 0.03 0.47 0.12 0.21
Iran (29) 0.11 0.37 0.07 0.10 0.12
Venezuela (73) 0.12 0.48 0.17 0.25 0.17 0.01
PNG (102) 0.19 0.42 0.06 0.22 0.17 0.26 0.25
Abbreviations: China-Myanmar China-Myanmar border population, PNG Papua New Guinea population
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Discussion
Consistent with worldwide reports, we detected high
genetic diversity in the ectodomain of Pvama1 sequences
obtained in 73 P. vivax isolates from the China-Myanmar
border. Globally, substantial geographic variability has
been observed, with lower diversity in East Asian (Korean,
π = 0.006 [47]) and South American (Venezuelan, π =
0.007 [50]) populations, compared to higher diversity in
Southeast Asian (Thai, π = 0.009 [48]) and West Asian
(Iranian, π = 0.010 [49]) populations. As genetic diversity
of P. vivax populations varies significantly due to trans-
mission intensity [62–64], it is likely that the higher gen-
etic diversity observed in Thailand and Iran was due to
higher P. vivax transmission intensity than in Korea and
Venezuela. The detected high level of genetic diversity in
Pvama1 in parasite population from the China-Myanmar
border was not in line with the rapid decline of malaria in-
cidence in recent years. While it is expected that genetic
diversity diminishes following the reduction in malaria in-
cidence, the relationship between the two aspects is com-
plex and could vary according to many epidemiological
parameters. In Thailand, for example, P. vivax population
in the western border was highly diverse as compared to
being almost clonal in the southern border [9, 10]. It re-
mains to be determined whether these differences were
due to different histories of malaria control efforts and
levels of parasite introduction from neighboring highly
endemic areas. Nevertheless, with the overall increased
control efforts in the GMS and more isolated parasite
populations on the international borders, future longi-
tudinal tracking of parasite genetic diversity in the local
parasite populations as well as in potential sources of
parasite introduction will provide answers to these ques-
tions. Meanwhile, the use of more than one genetic marker
such as a molecular barcode may provide a better reso-
lution of the parasite populations [65].
The LD indices decline rapidly with the increasing
distance between sites. Considering the high values of
recombination parameter, C (C = 4Nr), these results in-
dicate that recombination is very frequent in the Pvama1
gene of diverse geographic populations [32, 37, 38, 47–50].
An estimated moderate level of the recombination param-
eter C (both between adjacent site, Ra and per gene, Rb)
was detected for Pvama1 (0.043 and 25.5) in the China-
Myanmar border population. This C value observed for
Pvama1 is much higher than that of Pfama1 (0.003 and
3.8) from a sympatric population of P. falciparum [66], for
which the effective population size (Ne) is only 1.3 × 10
3
when calculated by using the average recombination rate
of P. falciparum (~6 × 10-7 Morgans/base) [67]. We
conclude from these data that recombination events in
Pvama1 of the China-Myanmar border population are
common, and that this area appears to have a consider-
ably larger effective population of P. vivax than P. fal-
ciparum. In P. falciparum, strong LD and low genetic
diversity often are observed in low-transmission areas
[68]. However, such a spectrum of population structures
may not fit for P. vivax populations, as we observed LD
and high-level haplotype diversity (0.958) of Pvama1 in
the China-Myanmar border, where malaria transmission is
low [8]. We speculate that two factors might contribute to
the observed high genetic diversity in Pvama1 in the
border regions. The ability to relapse in P. vivax increases
the prevalence of mixed infections and chances for genetic
Fig. 3 Natural selection on Pvama1 isolates from the China-Myanmar
border area. Sliding-window plots of Tajima’s D test (a), Fu and Li’s D*
(b) and F* (c) tests for Pvama1 were shown. Nucleotide numbers follow
those of Sal-I. Window length is 90 bp, and step size is 3 bp. The three
domains of AMA1 (Domain I, Domain II, and Domain III) are shown. Blue
lines indicate the region with a significant departure from neutrality
(P < 0.1, one-tailed). Red lines indicate regions with positive values
(P < 0.05, one-tailed)
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recombination in the mosquito vectors. In addition, heavy
human population flow across the porous international
borders further favors mixing of parasite populations and
increasing parasite genetic diversity.
Pairwise FST comparisons only detected a moderate
level of genetic differentiation (FST = 0.23) among global
populations. This may reflect the functional constraints
of this protein and similar balancing selection from hu-
man immunity on this protein. Despite this, major geo-
graphical genetic differentiation does exist. For instance,
the Korean parasite population was drastically different
from other parasite populations from the world. The
Fig. 4 The proportion of Pvama1 haplotype variations observed in different geographical populations. The size of the pie reflects the frequency
of a particular haplotype. The lengths of the lines connecting the pies, measured from their centers, are in proportion to the number of base pair
substitutions separating the haplotypes. Color of each pie represents different country. The torso of the haplotype network is shown with light
red shadow. Abbreviation: H21, haplotype 21
Fig. 5 CPK-models of PvAMA1 with IURs, predicted B-cell epitopes, and polymorphic residues across DI-III mapped. Two opposite sides of the
same 3-D structure are shown in (a) with and in (b) without the polymorphic residues. Residues in overlapped regions of B-cell epitopes and IURs
with polymorphic residues (aa 121–141, 392–406, and 427–441) are shown in yellow, while overlapped regions without polymorphic residues
(aa 171–183 and 291–309) are shown in red. Polymorphic residues across DI-III are shown in pink. Other amino acids are shown in white
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Thai P. vivax populations collected from three regions
(northwestern, eastern and southern) from 1996 and
2007 also showed significant population subdivision
[48], which may be due to temporal and spatial separa-
tions among these populations. Later studies confirmed
that the southern Thai population had experienced a
genetic bottleneck with significantly reduced genetic di-
versity [9, 10]. Yet, very little genetic differentiation was
observed between the combined Thai parasite popula-
tion and the China-Myanmar border population, despite
that our parasite samples were acquired more recently.
This demonstrates the persistence of highly diverse P.
vivax populations with only slight genetic differentiation
in different regions of the GMS, suggesting the lack of
major gene flow barriers in this region. Together with
the fact that similar allelic forms of Pvama1 are circulat-
ing in the Myanmar, China-Myanmar border, and Thai
P. vivax populations [48, 59], the low genetic differenti-
ation between these regions support the idea that a gen-
eral malaria elimination or control strategy may be
applicable for these endemic regions.
The pattern of polymorphisms observed in the ectodo-
main as well as DI of the China-Myanmar border Pvama1
showed that both domains are under diversifying selec-
tion, suggesting a significant departure from neutrality as
confirmed by the McDonald and Kreitman test. These re-
sults are consistent with previous reports of Pvama1 DI
from various global isolates [32, 37, 38, 47–50]. Although
DII of Pvama1 has been reported as highly immunogenic
[33, 69], and there is evidence of positive selection in DII
of Sri Lankan P. vivax populations [32], no evidence was
found for diversifying selection on DII and DIII of the
China-Myanmar border Pvama1 as confirmed by neutral-
ity tests, which is in agreement with several other reports
[37, 50]. These results suggest that DI is the dominant tar-
get of the host immune response.
A total of 308 haplotypes, with a haplotype diversity of
0.988, was identified in global isolates when analyzing
the ectodomain of Pvama1. This extreme polymorphism
indicates that each haplotype might be recognized as im-
munologically distinct by the immune system. Further
observation of Pvama1 DI showed that only haplotype
30 in the China-Myanmar border is shared with popula-
tions outside of Asia, and haplotype 10 is the only one
shared among the majority of analyzed Asian populations.
Together with the complex network analysis results, cov-
ering diversity of P. vivax will be a great challenge for a
PvAMA1-based vaccine design. Although highly diverse,
the observation that the majority of the China-Myanmar
border Pvama1 haplotypes (44.4%) are shared with Thai
populations and that the dominant haplotype (H21) is
identical in both populations suggested little differenti-
ation of parasite populations within GMS, and a
PvAMA1-based malaria vaccine may be effective in this
entire region. Notably, the vaccine strain Sal-I haplotype
was not identified in any of the analyzed population in the
current study. Thus, the dominant Pvama1 alleles from
field parasite populations should be considered in the fu-
ture studies.
Compared to the Sal-I sequence, 46 SNPs resulting in
43 amino acid substitutions were identified in the China-
Myanmar border Pvama1. The majority of the diversity
clustered within Pvama1 DI, as has been reported previ-
ously for P. falciparum and P. vivax [29, 37, 50]. The 90.7%
(39/43) polymorphic sites within the ectodomain identified
in the China-Myanmar border Pvama1 are comparable to
those previously reported [32, 37, 38, 47–50], indicating
that these sites may be under strong natural selection. Four
clusters within DI (c1, c1L, c2 and c3) were mapped to the
surface of the PfAMA1 protein and are potentially associ-
ated with antigenic escape [70, 71]. In P. falciparum, the c1
(positions 187 to 231) and c1L (positions 196–207) clusters
contain the most polymorphic residues [70, 71]. How-
ever, only four Pvama1 polymorphic sites of the China-
Myanmar border isolates were located in the Pfama1
c1 cluster. These mutation sites are comparable with
those observed in the PNG isolates [37], supporting the
hypothesis that the presentation of the PvAMA1’s DI
loops is different from that of PfAMA1. Structural model-
ing of PvAMA1 from the China-Myanmar border isolates
revealed that all of the polymorphic residues are mapped
to one surface of the PvAMA1 protein, suggesting this is
the side face exposed to the host immune system [29].
Previous studies by using invasion-inhibitory monoclonal
antibodies specific for PfAMA1 revealed that DII of
PvAMA1 is a target of the protective immune response.
Furthermore, IUR region (aa 290–307) in the DII of
PvAMA1 was found to be an important antigenic re-
gion during natural human infections [52]. Comparable
to these previous reports, amino acid sequence conser-
vation has also been identified in China-Myanmar
border isolates, with no polymorphic sites in aa 171–183
(in DI) and 291–309 (in DII) of B-cell epitope and IUR
overlapped region have been identified in all 73 sequenced
samples. The current results support the inclusion of
amino acid sequences aa 291–309 in DII in PvAMA1-
based vaccine.
Conclusions
Our study demonstrated that the genetic diversity of the
Pvama1 in 73 P. vivax isolates from the China-Myanmar
border area, as well as global isolates, was exceptionally
high, and that Pvama1 DI is the dominant target of posi-
tive diversifying selection. Furthermore, a low level of gen-
etic differentiation among the Myanmar, China-Myanmar
border and Thai populations suggests high levels of gene
flow within the GMS.
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Additional file 1: Table S1. Oligonucleotides used for amplification
and sequencing of Pvama1 gene sequences. (DOCX 14 kb)
Additional file 2: Figure S1. Alignment of P. falciparum, P. vivax, and P.
cynomolgi AMA1 protein sequences. P. falciparum 3D7 (PlasmoDB ID:
PF3D7_1133400), P. vivax Sal-I (GenBank access no. AF063138) and P.
cynomolgi (GenBank access no. X86099) were aligned using MUltiple
Sequence Comparison by Log-Expectation (MUSCLE, http://www.ebi.ac.uk/
Tools/mas/muscle/). Gaps are indicating by dashes. Conserved amino acids
among the three analyzed strains are marked by asterisks. Red bold types
indicate conserved cysteine residues that divide the ectodomain of AMA1.
Domains I-III is shown in grey, green and yellow color, respectively. Boxes
indicate c1, c2, and c3 clusters. The c1L cluster region is marked with
underlines. Light blue bold type indicates residues that are polymorphic
in P. vivax of China-Myanmar border isolates. (TIF 2305 kb)
Additional file 3: Figure S2. Patterns of nucleotide diversity and amino
acid polymorphisms of Pvama1. Sliding window plot of nucleotide diversity
(π) and amino acid polymorphism of Pvama1 ectodomain in 607 global
isolates and 8 reference strains were shown. The π value was calculated
using DnaSP v5.10.01 with window length of 90 bp and step size of 3 bp
Domain I is highlighted in red color. Nucleotide and amino acid positions
are after the Sal-I sequence. (TIF 183 kb)
Additional file 4: Figure S3. Phylogenetic analysis of China-Myanmar
border and Myanmar Pvama1 sequences. The tree was constructed by
analyzing DI (nt, 322–737) with 73 Pvama1 sequences obtained from
China-Myanmar border and 24 Pvama1 sequences obtained from Myanmar
P. vivax isolates (GenBank accession nos. FJ157247, FJ157249, FJ157251,
FJ157253–FJ157269 and FJ157282–FJ157285) using a neighbor-joining
method. The bootstrap method with 1,000 replications was used to
construct the gene tree. Red circle indicate sequences obtained from
Myanmar. (TIF 1803 kb)
Additional file 5: Table S2. Genetic differentiation (FST) of the Pvama1
gene among Thai, Myanmar and China-Myanmar border populations
across DI. (DOCX 14 kb)
Additional file 6: Figure S4. The proportion of Pvama1 haplotypes
variation observed in China-Myanmar border, Myanmar, and Thai populations.
The size of the pies reflects the frequency of a particular haplotype. The
lengths of the lines connecting the pies, measured from their centers, are in
proportion to the number of base pair substitutions separating the
haplotypes. Color of each pie represents different country. Abbreviation: H21,
haplotype 21. (TIF 831 kb)
Additional file 7: Figure S5. Location of current study detected SNPs
in the predicted B-cell epitopes and IURs in PvAMA1. Predictions of B-cell
epitopes and IURs were performed by using ABCpred and RONN server,
respectively. The cysteine residues have been shown in red bold. DI = 94–247
aa; DII = 265–363 aa; DIII = 388–451 aa; SNPs in the current study were marked
in grey shadow; underlined shows B-cell epitopes; Bold overbars show IURs.
(TIF 323 kb)
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